| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.418 | 5.086 | 9.088 | 36.219 | 194.032 | 153.885 | 154.507 | 256.328 | 259.244 |
| Total Income - EUR | - | 2.418 | 5.086 | 9.088 | 36.219 | 194.032 | 153.948 | 154.523 | 258.247 | 271.513 |
| Total Expenses - EUR | - | 0 | 1.102 | 803 | 11.496 | 97.191 | 53.171 | 104.479 | 68.216 | 52.290 |
| Gross Profit/Loss - EUR | - | 2.418 | 3.984 | 8.285 | 24.722 | 96.841 | 100.777 | 50.044 | 190.031 | 219.223 |
| Net Profit/Loss - EUR | - | 2.345 | 3.831 | 8.013 | 24.038 | 95.242 | 99.269 | 48.534 | 187.775 | 211.601 |
| Employees | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Seygyn Clinique Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 96 | 95 | 93 | 36.445 | 40.471 | 39.300 | 66.804 | 331.655 | 306.427 |
| Current Assets | - | 2.488 | 6.235 | 11.830 | 14.928 | 128.830 | 73.275 | 83.219 | 312.163 | 193.917 |
| Inventories | - | 25 | 0 | 0 | 197 | 245 | 663 | 371 | 0 | 1.376 |
| Receivables | - | 1.410 | 929 | 7.163 | 4.478 | 584 | 111 | 68.537 | 288.662 | 91.960 |
| Cash | - | 1.052 | 5.306 | 4.667 | 10.254 | 128.001 | 72.501 | 14.311 | 23.501 | 100.581 |
| Shareholders Funds | - | 2.390 | 6.180 | 11.816 | 26.753 | 121.487 | 106.501 | 48.583 | 195.356 | 211.650 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 194 | 149 | 107 | 24.620 | 47.814 | 6.073 | 101.440 | 276.649 | 157.308 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 171.813 | 131.386 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Seygyn Clinique Srl